3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide

C55H64N10O6 — CID 123963616

IUPAC3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide
SMILESCCCN(C(=O)C(NC(=O)CCN(C)C)c1ccccc1)C(C)c1ncc(-c2cc3c4c(c2)OCc2cc(-c5cnc(C6CCCN6C(=O)C(NC(=O)CCN(C)C)c6ccccc6)[nH]5)cc(c2-4)OC3)[nH]1
InChIInChI=1S/C55H64N10O6/c1-7-22-64(54(68)50(35-15-10-8-11-16-35)60-46(66)20-24-62(3)4)34(2)52-56-30-41(58-52)37-26-39-32-71-45-29-38(27-40-33-70-44(28-37)48(39)49(40)45)42-31-57-53(59-42)43-19-14-23-65(43)55(69)51(36-17-12-9-13-18-36)61-47(67)21-25-63(5)6/h8-13,15-18,26-31,34,43,50-51H,7,14,19-25,32-33H2,1-6H3,(H,56,58)(H,57,59)(H,60,66)(H,61,67)
InChIKeyJSOBCIPJCHHLSH-UHFFFAOYSA-N
MW961.18 g/mol
LogP7.50
Rot. Bonds19

About 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide

3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide (PubChem CID 123963616) has the molecular formula C55H64N10O6 and a molecular weight of 961.18 g/mol. Its IUPAC name is 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide.

Molecular Properties

Compound Name3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide
PubChem CID123963616
Molecular FormulaC55H64N10O6
Molecular Weight961.18 g/mol
Exact Mass960.50
IUPAC Name3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide
SMILESCCCN(C(=O)C(NC(=O)CCN(C)C)c1ccccc1)C(C)c1ncc(-c2cc3c4c(c2)OCc2cc(-c5cnc(C6CCCN6C(=O)C(NC(=O)CCN(C)C)c6ccccc6)[nH]5)cc(c2-4)OC3)[nH]1
InChIInChI=1S/C55H64N10O6/c1-7-22-64(54(68)50(35-15-10-8-11-16-35)60-46(66)20-24-62(3)4)34(2)52-56-30-41(58-52)37-26-39-32-71-45-29-38(27-40-33-70-44(28-37)48(39)49(40)45)42-31-57-53(59-42)43-19-14-23-65(43)55(69)51(36-17-12-9-13-18-36)61-47(67)21-25-63(5)6/h8-13,15-18,26-31,34,43,50-51H,7,14,19-25,32-33H2,1-6H3,(H,56,58)(H,57,59)(H,60,66)(H,61,67)
InChIKeyJSOBCIPJCHHLSH-UHFFFAOYSA-N
XLogP7.50
TPSA181.12 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds19
Heavy Atoms71
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500961.18
LogP ≤ 57.50
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide?
The IUPAC name of 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide (CID 123963616) is 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide.
What is the SMILES notation for 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide?
The canonical SMILES for 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide is CCCN(C(=O)C(NC(=O)CCN(C)C)c1ccccc1)C(C)c1ncc(-c2cc3c4c(c2)OCc2cc(-c5cnc(C6CCCN6C(=O)C(NC(=O)CCN(C)C)c6ccccc6)[nH]5)cc(c2-4)OC3)[nH]1.
What is the InChIKey of 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide?
The InChIKey is JSOBCIPJCHHLSH-UHFFFAOYSA-N. The full InChI is InChI=1S/C55H64N10O6/c1-7-22-64(54(68)50(35-15-10-8-11-16-35)60-46(66)20-24-62(3)4)34(2)52-56-30-41(58-52)37-26-39-32-71-45-29-38(27-40-33-70-44(28-37)48(39)49(40)45)42-31-57-53(59-42)43-19-14-23-65(43)55(69)51(36-17-12-9-13-18-36)61-47(67)21-25-63(5)6/h8-13,15-18,26-31,34,43,50-51H,7,14,19-25,32-33H2,1-6H3,(H,56,58)(H,57,59)(H,60,66)(H,61,67).
What are the key properties of 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide?
3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide has a molecular weight of 961.18 g/mol, XLogP of 7.50, 19 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(dimethylamino)-N-[2-[2-[5-[13-[2-[1-[[2-[3-(dimethylamino)propanoylamino]-2-phenylacetyl]-propylamino]ethyl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]propanamide is sourced from PubChem (CID 123963616), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).